Regulation of fatty acid uptake and metabolism in L6 skeletal muscle cells by resistin

被引:121
作者
Palanivel, R [1 ]
Sweeney, G [1 ]
机构
[1] York Univ, Dept Biol, N York, ON M3J 1P3, Canada
来源
FEBS LETTERS | 2005年 / 579卷 / 22期
基金
加拿大创新基金会; 加拿大自然科学与工程研究理事会;
关键词
D O I
10.1016/j.febslet.2005.08.011
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Resistin has been proposed as a potential link between obesity and insulin resistance. It is also well established that altered metabolism of fatty acids by skeletal muscle can lead to insulin resistance and lipotoxicity. However, little is known about the effect of resistin on long chain fatty acid uptake and metabolism in skeletal muscle. Here we show that treating rat skeletal muscle cells with recombinant resistin (50 nM, 24 h) decreased uptake of palmitate. This correlated with reduced cell surface CD36 content and lower expression of FATP1, but no change in FATP4 or CD36 expression. We also found that resistin decreased fatty acid oxidation by measuring (CO2)-C-14 production from [1-C-14] oleate and an increase in intracellular lipid accumulation was detected in response to resistin. Decreased AMPK and ACC phosphorylation were observed in response to resistin while expression of ACC and AMPK isoforms was unaltered. Resistin mediated these effects without altering cell viability. In summary, our results demonstrate that chronic incubation of skeletal muscle cells with resistin decreased fatty acid uptake and metabolism via a mechanism involving decreased cell surface CD36 content, FATP1 expression and a decrease in phosphorylation of AMPK and ACC. (c) 2005 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:5049 / 5054
页数:6
相关论文
共 34 条
[1]   Plasma resistin concentration, hepatic fat content, and hepatic and peripheral insulin resistance in pioglitazone-treated type II diabetic patients [J].
Bajaj, M ;
Suraamornkul, S ;
Hardies, LJ ;
Pratipanawatr, T ;
DeFronzo, RA .
INTERNATIONAL JOURNAL OF OBESITY, 2004, 28 (06) :783-789
[2]   Regulation of fasted blood glucose by resistin [J].
Banerjee, RR ;
Rangwala, SM ;
Shapiro, JS ;
Rich, AS ;
Rhoades, B ;
Qi, Y ;
Wang, J ;
Rajala, MW ;
Pocai, A ;
Scherer, PE ;
Steppan, CM ;
Ahima, RS ;
Obici, S ;
Rossetti, L ;
Lazar, MA .
SCIENCE, 2004, 303 (5661) :1195-1198
[3]   Fatty acid metabolism in obesity and type 2 diabetes mellitus [J].
Blaak, EE .
PROCEEDINGS OF THE NUTRITION SOCIETY, 2003, 62 (03) :753-760
[4]   Globular adiponectin increases GLUT4 translocation and glucose uptake but reduces glycogen synthesis in rat skeletal muscle cells [J].
Ceddia, RB ;
Somwar, R ;
Maida, A ;
Fang, X ;
Bikopoulos, G ;
Sweeney, G .
DIABETOLOGIA, 2005, 48 (01) :132-139
[5]   5'-AMP inhibits dephosphorylation, as well as promoting phosphorylation, of the AMP-activated protein kinase. Studies using bacterially expressed human protein phosphatase-2C alpha and native bovine protein phosphatase-2A(c) [J].
Davies, SP ;
Helps, NR ;
Cohen, PTW ;
Hardie, DG .
FEBS LETTERS, 1995, 377 (03) :421-425
[6]   Serum resistin (FIZZ3) protein is increased in obese humans [J].
Degawa-Yamauchi, M ;
Bovenkerk, JE ;
Juliar, BE ;
Watson, W ;
Kerr, K ;
Jones, R ;
Zhu, QH ;
Considine, RV .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (11) :5452-5455
[7]   Resistin release by human adipose tissue explants in primary culture [J].
Fain, JN ;
Cheema, PS ;
Bahouth, SW ;
Hiler, ML .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 300 (03) :674-678
[8]   The genomic organization of mouse resistin reveals major differences from the human resistin: functional implications [J].
Ghosh, S ;
Singh, AK ;
Aruna, B ;
Mukhopadhyay, S ;
Ehtesham, NZ .
GENE, 2003, 305 (01) :27-34
[9]  
GRAVELEAU C, 2005, J BIOL CHEM 0627
[10]   The AMP-activated protein kinase pathway - new players upstream and downstream [J].
Hardie, DG .
JOURNAL OF CELL SCIENCE, 2004, 117 (23) :5479-5487